Bank Of America Corp Jounce Therapeutics, Inc. Transaction History

Bank Of America Corp

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	SELL	$0.9 - $1.85 $2.92 Million - $5.99 Million	-3,239,186 Reduced 98.86%	37,513 $69,000
Q4 2022 Feb 10, 2023	BUY	$0.64 - $1.99 $2.09 Million - $6.5 Million	3,265,185 Added 28358.39%	3,276,699 $3.64 Million
Q3 2022 Nov 14, 2022	BUY	$2.73 - $4.92 $7,420 - $13,372	2,718 Added 30.9%	11,514 $27,000
Q2 2022 Aug 12, 2022	SELL	$2.8 - $7.67 $110,048 - $301,454	-39,303 Reduced 81.71%	8,796 $26,000
Q1 2022 May 16, 2022	SELL	$6.01 - $8.54 $79,289 - $112,668	-13,193 Reduced 21.52%	48,099 $327,000
Q4 2021 Feb 08, 2022	BUY	$7.11 - $9.64 $369,641 - $501,173	51,989 Added 558.84%	61,292 $512,000
Q3 2021 Nov 15, 2021	SELL	$5.04 - $8.73 $19,751 - $34,212	-3,919 Reduced 29.64%	9,303 $69,000
Q2 2021 Sep 13, 2021	BUY	$6.58 - $10.66 $87,000 - $140,946	13,222 New	13,222 $90,000

720K

Ticker JNCE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 51,694,200
Description
Jounce Therapeutics, Inc., a clinical-stage immunotherapy company, develops therapies for the treatment of cancer. The company develops vopratelimab, a clinical-stage monoclonal antibody, which is in Phase II clinical trial that binds to and activates the Inducible T cell CO-Stimulator, a protein on the surface of T cells found in various solid ...

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

Stay updated on Bank Of America Corp with notifications on news.